Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cyran

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|December 28, 2020
<sup>18</sup>F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary resultsL M Mittlmeier, M Unterrainer, S Rodler, et al.
European Journal of Radiology|December 10, 2024
Replication study of PD-L1 status prediction in NSCLC using PET/CT radiomicsAnna Theresa Stüber, Maurice M Heimer, Johanna Ta, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 9, 2021
<sup>18</sup>F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluationFelix G Gassert, Johannes Rübenthaler, Clemens C Cyran, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 2, 2014
In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast mediaClemens C Cyran, Bettina Schwarz, Philipp M Paprottka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2017
Improved Detection of Transosseous Meningiomas Using <sup>68</sup>Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRIWolfgang G Kunz, Lisa M Jungblut, Philipp M Kazmierczak, et al.
AJR. American Journal of Roentgenology|January 24, 2012
Perfusion MRI for monitoring the effect of sorafenib on experimental prostate carcinoma: a validation studyClemens C Cyran, Philipp M Paprottka, Bettina Schwarz, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 17, 2025
Digital Transformation and Artificial Intelligence in Radiology: Challenges and Opportunities for Clinical Practice, Research, and the Next GenerationEmily Hoffmann, Peter Bannas, Nadine Bayerl, et al.
Investigative Radiology|March 18, 2025
Performance of an Intravascular Tantalum Oxide-Based Nanoparticle Computed Tomography Contrast Agent in Preclinical Hepatic Tumor DetectionMaurice M Heimer, Yuxin Sun, Peter J Bonitatibus, et al.
Investigative Radiology|September 22, 2011
Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomasClemens C Cyran, Jobst C von Einem, Philipp M Paprottka, et al.
Epidemiology and Infection|August 18, 2004
Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of FranceD Lucidarme, A Bruandet, D Ilef, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
European Journal of Nuclear Medicine and Molecular Imaging|December 28, 2020
<sup>18</sup>F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary resultsL M Mittlmeier, M Unterrainer, S Rodler, et al.
European Journal of Radiology|December 10, 2024
Replication study of PD-L1 status prediction in NSCLC using PET/CT radiomicsAnna Theresa Stüber, Maurice M Heimer, Johanna Ta, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 9, 2021
<sup>18</sup>F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluationFelix G Gassert, Johannes Rübenthaler, Clemens C Cyran, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 2, 2014
In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast mediaClemens C Cyran, Bettina Schwarz, Philipp M Paprottka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2017
Improved Detection of Transosseous Meningiomas Using <sup>68</sup>Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRIWolfgang G Kunz, Lisa M Jungblut, Philipp M Kazmierczak, et al.
AJR. American Journal of Roentgenology|January 24, 2012
Perfusion MRI for monitoring the effect of sorafenib on experimental prostate carcinoma: a validation studyClemens C Cyran, Philipp M Paprottka, Bettina Schwarz, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 17, 2025
Digital Transformation and Artificial Intelligence in Radiology: Challenges and Opportunities for Clinical Practice, Research, and the Next GenerationEmily Hoffmann, Peter Bannas, Nadine Bayerl, et al.
Investigative Radiology|March 18, 2025
Performance of an Intravascular Tantalum Oxide-Based Nanoparticle Computed Tomography Contrast Agent in Preclinical Hepatic Tumor DetectionMaurice M Heimer, Yuxin Sun, Peter J Bonitatibus, et al.
Investigative Radiology|September 22, 2011
Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomasClemens C Cyran, Jobst C von Einem, Philipp M Paprottka, et al.
Epidemiology and Infection|August 18, 2004
Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of FranceD Lucidarme, A Bruandet, D Ilef, et al.
Pageof 14